• Tidak ada hasil yang ditemukan

SUPPLEMENTAL DIGITAL CONTENT 4.

N/A
N/A
Protected

Academic year: 2024

Membagikan "SUPPLEMENTAL DIGITAL CONTENT 4."

Copied!
3
0
0

Teks penuh

(1)

SUPPLEMENTAL DIGITAL CONTENT 4. Cumulative incidence of mental health conditions among women who did not have any of the 20 chronic conditions at baseline, overall and in strata by age at hysterectomy and by indication

Hysterectomy Referent women Unadjusted modelsa Adjusted modelsb

Condition N at

risk

Person- years

N of events

N at risk

Person- years

N of events

Hazard ratio

(95% CI) P Hazard ratio

(95% CI) P

Overall

Depression 1,204 22,127 378 1,433 25,641 339 1.30 (1.12-1.49) <0.001 1.31 (1.14-1.51) <0.001 Anxiety 1,204 23,492 302 1,433 26,726 279 1.23 (1.05-1.44) 0.01 1.24 (1.06-1.45) 0.008 Substance

abuse disorders 1,204 26,779 49 1,433 29,412 43 1.26 (0.84-1.89) 0.25 1.28 (0.85-1.92) 0.24 Dementia 1,204 26,981 68 1,433 29,625 63 1.07 (0.77-1.49) 0.69 1.08 (0.78-1.52) 0.64 Schizophrenia

and psychosis 1,204 27,139 20 1,433 29,753 28 0.72 (0.41-1.28) 0.27 0.79 (0.44-1.41) 0.43 Age 18-35 years

Depression 326 5,582 114 424 7,108 101 1.43 (1.10-1.87) 0.008 1.46 (1.12-1.92) 0.006

Anxiety 326 5,990 97 424 7,551 76 1.63 (1.21-2.19) 0.001 1.65 (1.22-2.23) 0.001

Substance

abuse disorders 326 6,968 23 424 8,264 17 1.61 (0.88-2.96) 0.12 1.55 (0.83-2.87) 0.17

Dementia 326 7,175 9 424 8,430 7 1.49 (0.59-3.74) 0.40 0.99 (0.39-2.53) 0.99

Schizophrenia

and psychosis 326 7,209 2 424 8,451 3 0.78 (0.13-4.58) 0.78 0.63 (0.10-3.99) 0.63 Age 36-50 years

Depression 760 14,351 229 891 16,373 207 1.27 (1.05-1.52) 0.01 1.28 (1.06-1.54) 0.009 Anxiety 760 15,225 180 891 16,928 185 1.08 (0.88-1.32) 0.46 1.08 (0.89-1.33) 0.43 Substance

abuse disorders 760 17,326 23 891 18,772 20 1.26 (0.69-2.28) 0.45 1.23 (0.68-2.25) 0.50 Dementia 760 17,441 24 891 18,944 20 1.26 (0.70-2.27) 0.45 1.28 (0.71-2.33) 0.41 Schizophrenia

and psychosis 760 17,489 9 891 18,970 13 0.74 (0.32-1.71) 0.48 0.86 (0.36-2.03) 0.73

(2)

SUPPLEMENTAL DIGITAL CONTENT 4. Continued

Hysterectomy Referent women Unadjusted modelsa Adjusted modelsb

Condition N at

risk

Person- years

N of events

N at risk

Person- years

N of events

Hazard ratio

(95% CI) P Hazard ratio

(95% CI) P

Age >50 years

Depression 118 2,194 35 118 2,160 31 1.14 (0.71-1.83) 0.58 1.17 (0.73-1.88) 0.51

Anxiety 118 2,278 25 118 2,247 18 1.34 (0.74-2.42) 0.34 1.40 (0.76-2.55) 0.28

Substance

abuse disorders 118 2,485 3 118 2,377 6 0.47 (0.12-1.88) 0.29 0.52 (0.13-2.08) 0.36

Dementia 118 2,365 35 118 2,251 36 0.89 (0.56-1.41) 0.63 0.99 (0.62-1.57) 0.96

Schizophrenia

and psychosis 118 2,441 9 118 2,333 12 0.69 (0.29-1.63) 0.39 0.72 (0.30-1.70) 0.45 Leiomyomasc

Depression 452 8,285 124 525 9,038 123 1.11 (0.87-1.43) 0.39 1.11 (0.87-1.42) 0.41

Anxiety 452 8,507 106 525 9,390 101 1.16 (0.88-1.52) 0.29 1.16 (0.88-1.52) 0.29

Substance

abuse disorders 452 9,743 18 525 10,427 14 1.40 (0.70-2.81) 0.34 1.42 (0.71-2.86) 0.32

Dementia 452 9,824 25 525 10,507 20 1.03 (0.57-1.84) 0.93 1.08 (0.60-1.93) 0.80

Schizophrenia

and psychosis 452 9,829 9 525 10,555 9 0.99 (0.39-2.48) 0.98 1.07 (0.42-2.70) 0.89 Menstrual disordersc

Depression 324 6,042 114 385 7,089 97 1.38 (1.05-1.80) 0.02 1.41 (1.07-1.85) 0.01

Anxiety 324 6,497 94 385 7,453 77 1.41 (1.05-1.89) 0.02 1.44 (1.06-1.95) 0.02

Substance

abuse disorders 324 7,475 16 385 8,224 10 1.84 (0.84-4.04) 0.13 2.10 (0.94-4.68) 0.07

Dementia 324 7,633 11 385 8,306 14 0.85 (0.38-1.89) 0.69 0.78 (0.35-1.78) 0.56

Schizophrenia

and psychosis 324 7,644 5 385 8,332 5 1.06 (0.31-3.68) 0.93 1.25 (0.34-4.62) 0.74

(3)

SUPPLEMENTAL DIGITAL CONTENT 4. Continued

Hysterectomy Referent women Unadjusted modelsa Adjusted modelsb

Condition N at

risk

Person- years

N of events

N at risk

Person- years

N of events

Hazard ratio

(95% CI) P Hazard ratio

(95% CI) P

Uterine prolapsec

Depression 235 4,462 68 300 5,474 72 1.14 (0.82-1.58) 0.43 1.17 (0.84-1.62) 0.36

Anxiety 235 4,761 54 300 5,634 61 1.01 (0.71-1.44) 0.96 1.01 (0.71-1.44) 0.96

Substance

abuse disorders 235 5,318 7 300 6,222 9 0.89 (0.34-2.32) 0.81 0.90 (0.34-2.36) 0.83

Dementia 235 5,260 25 300 6,222 21 1.31 (0.74-2.34) 0.36 1.36 (0.76-2.43) 0.31

Schizophrenia

and psychosis 235 5,374 5 300 6,235 11 0.45 (0.16-1.25) 0.13 0.49 (0.17-1.40) 0.18

a Hazard ratios calculated using Cox proportional hazards models with age as the time scale.

b Hazard ratios calculated using Cox proportional hazards models with age as the time scale and adjusted using inverse probability weights derived from a logistic regression model including all 20 chronic conditions present at baseline (index date), years of education (≤12, 13-16, >16, unknown), race (white vs nonwhite), and age and calendar year at baseline (continuous). These adjustments were performed separately in each stratum to maximize the balance at baseline. Overall interactions by age (18-35, 36-50, >50 years) were assessed for each mental health condition: depression P=0.10, anxiety P=0.48, substance abuse disorders P=0.12, dementia P=0.64, and schizophrenia and psychosis P=0.83. Similarly, overall

interactions by indication (leiomyomas, menstrual disorders, uterine prolapse) were assessed for each mental health condition: depression P=0.14, anxiety P=0.43, substance abuse disorders P=0.72, dementia P=0.80, and schizophrenia and psychosis P=0.54.

c A total of 308 women with other non-cancer indications for hysterectomy were not included in the analyses stratified by indication.

Referensi

Dokumen terkait

Koponen et al, 2012 RCT SimP group Theater group 13 Communication Skills Attitude Scale: instrument with published validity data PRP=SimP=Theater Koponen et al, 2014 RCT SimP

Based on the results of financial distress predictions using cox proportional hazard regression in coal subsector companies listed on the Indonesia Stock Exchange for the period

[r]

The concentration-QTc/RR analysis was performed using data from a subset of patients in the QTc evaluation population who had received at least 1 dose of palbociclib and had at least 1

Sensitivity analyses of coxibs versus relatively selective COX-2 inhibitors according to sample size and study quality.. Study Participant RR95%CI Ulcer complications Sample size

SDC 1 – Combined Supplemental Digital Content SDC 4 - Supplemental Materials and Methods Quantitative Reverse Transcribed-PCR of Intracellular Cytokines and FoxP3 from CD3+ T-cells

Time-Varying Model Example: Fit Model to Simulated Data Using SAS Proc Calis 11 Data Simulated Using Estimated Parameters for Protein Intake in Men in VSPP 16:51 Monday, July 27,